Analyst Price Targets — SGHT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 2, 2026 1:19 pm | — | Cantor Fitzgerald | $8.00 | $5.44 | StreetInsider | Sight Sciences Inc. (SGHT) PT Raised to $8 at Stifel Following Optometrist Survey |
| January 5, 2026 10:56 am | Matt O'Brien | Piper Sandler | $9.00 | $7.48 | TheFly | Sight Sciences upgraded to Overweight from Neutral at Piper Sandler |
| January 5, 2026 8:54 am | — | Raymond James | $9.00 | $7.48 | StreetInsider | Piper Sandler Upgrades Sight Sciences Inc. (SGHT) to Overweight |
| December 23, 2025 12:54 am | — | UBS | $12.00 | $8.44 | TheFly | Sight Sciences price target raised to $12 from $7 at UBS |
| December 10, 2025 1:58 pm | — | Lake Street | $12.00 | $8.47 | TheFly | Sight Sciences price target raised to $12 from $7 at Lake Street |
| December 2, 2025 11:38 am | Patrick Wood | Morgan Stanley | $8.00 | $8.17 | TheFly | Sight Sciences price target raised to $8 from $6 at Morgan Stanley |
| October 21, 2025 12:43 pm | — | Lake Street | $7.00 | $4.57 | TheFly | Sight Sciences price target raised to $7 from $5 at Lake Street |
| June 18, 2025 10:50 am | Matt O'Brien | Piper Sandler | $4.00 | $4.27 | TheFly | Sight Sciences price target raised to $4 from $3.50 at Piper Sandler |
| March 6, 2025 12:00 pm | — | Stifel Nicolaus | $4.00 | $2.49 | TheFly | Sight Sciences price target lowered to $4 from $5 at Stifel |
| November 4, 2024 1:08 pm | Frank Takkinen | Loop Capital Markets | $5.00 | $4.66 | StreetInsider | Lake Street Capital Markets Downgrades Sight Sciences Inc. (SGHT) to Hold |
Latest News for SGHT
Sight Sciences, Inc. (NASDAQ: SGHT - Get Free Report) EVP Brenton Taylor sold 2,869 shares of the stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $3.70, for a total value of $10,615.30. Following the completion of the sale, the executive vice president directly owned 267,807
Sight Sciences, Inc. (NASDAQ: SGHT - Get Free Report) CTO David Badawi sold 8,168 shares of Sight Sciences stock in a transaction that occurred on Thursday, April 2nd. The shares were sold at an average price of $3.48, for a total transaction of $28,424.64. Following the transaction, the chief technology officer directly owned 1,990,290 shares in
Sight Sciences, Inc. (NASDAQ: SGHT - Get Free Report) CEO Paul Badawi sold 29,244 shares of Sight Sciences stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $3.70, for a total value of $108,202.80. Following the sale, the chief executive officer directly owned 6,151,156 shares in the company,
MENLO PARK, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today announced that data on two of its proprietary glaucoma and dry eye technologies, the OMNI® Surgical System and the TearCare®…
MENLO PARK, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today announced plans to present at the 25th Annual Needham Healthcare Conference being held virtually.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SGHT.
U.S. House Trading
No House trades found for SGHT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.